antagonist D (ICRF)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantagonist D (ICRF)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth factor receptors antagonists
TargetsGrowth factor receptors
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImperial Cancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArana Therapeutics LtdThe UK Imperial Cancer Research Fund
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A